15th Sep 2006 07:00
International Medical Devices PLC15 September 2006 15th September 2006 International Medical Devices Plc Trading Statement re Year End 31st August 2006 • Integration of Meddis' logistics and administration successfully completed and will yield material savings • All 3 Group divisions traded to plan during the summer period • Growth through acquisition to continue • New product launches expected Q4 IMD Plc's three divisions - Aged / Home Care (EMS Medical and Response Medical),Emergency Care (Response Medical) and Surgical/Acute Care (Meddis) traded toplan during the summer months. Particularly Response Medical made good progress with the Welch Allyn PropaqMonitors, following the award of Welch Allyn's exclusive Distribution Agreementfor the UK ambulance services. The Ypsomed range of diabetic needles is ahead oftarget, with new product launches due in October. Response Medical was awardedexclusive UK rights to A & E departments and theatre recovery for CPAP, acontinuous airway pressure system, from major principal Respironics Inc.. Historically, IMD Plc has raised funding of £4.3 million which has been appliedto the acquisition of three medical device distribution businesses and thepatents for safe needles. Today the Group's pro-forma turnover over a 12 monthperiod would show sales in excess of £10 million. Results to 31st August 2006will show a small loss due to the timing of the acquisitions/ consolidationprocess and will not include full year sales, costs and profits for any of theacquisitions. However all three entities are trading satisfactorily. The Board intends to continue their growth by a process of acquiring establishedprofitable medical device distribution businesses. Our "Clip-on" safe needle is completing its sterilisation tests for the CEmarking process and it is hoped that a launch of the product will take place byDecember. First orders have been placed on our Australian supplier, Eastland MedicalSystems Ltd and positive feedback continues from the NHS clinicians with whom wehave been consulting in order to finalise the product design of "Clip-on". Preliminary results will be announced on October 11th 2006 with the AGMscheduled for Friday November 3rd 2006. C.R.C. THOMAS Chief Executive Ends Further Enquiries International Medical Devices Corporate Synergy Parkgreen CommunicationsChris Thomas Ian Rice Victoria ThomasCEO+44 203 008 4960 +44 117 933 0020 +44 207 493 3713 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Intelliam Ai